BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 15706409)

  • 21. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N; Sun ZZ; Li F; Cao YW; Zhao CX; Liang WH; Sun HP; Li HA; Fu XG
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):324-9. PubMed ID: 21756827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
    Thor AD; Moore DH II; Edgerton SM; Kawasaki ES; Reihsaus E; Lynch HT; Marcus JN; Schwartz L; Chen LC; Mayall BH
    J Natl Cancer Inst; 1992 Jun; 84(11):845-55. PubMed ID: 1317462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
    Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
    Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Node status in 454 ductal breast cancers cases according to the association with in situ component].
    Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J
    Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].
    Zhang B; Liu FF; Ma YJ; Gu F
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):904-9. PubMed ID: 24506959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival.
    Kostadima L; Pentheroudakis G; Fountzilas G; Dimopoulos M; Pectasides D; Gogas H; Stropp U; Christodoulou C; Samantas E; Wirtz R; Hennig G; Bafaloukos D; Arapantoni P; Kalofonos H; Papakostas P; Economopoulos T; Bamias A; Pavlidis N
    Breast Cancer Res Treat; 2006 Nov; 100(2):161-7. PubMed ID: 16823513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.
    du Toit RS; Locker AP; Ellis IO; Elston CW; Nicholson RI; Robertson JF; Blamey RW
    Eur J Surg Oncol; 1991 Jun; 17(3):251-7. PubMed ID: 1646127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
    Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
    Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Loss of fragile histidine triad expression and metastasis in breast cancer].
    Zhao P; Li XY; Chen LZ
    Ai Zheng; 2002 Jun; 21(6):668-70. PubMed ID: 12452072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.
    Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM
    Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases].
    Hauser H; Beham A; Steindorfer P; Smola MG; Fruhwirth H; Klimpfinger M
    Wien Klin Wochenschr; 1992; 104(23):717-20. PubMed ID: 1335634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the immunohistochemical expression of mammaglobin A in primary breast carcinoma and lymph node metastasis.
    Raica M; Cîmpean AM; Meche A; Alexa A; Suciu C; Mureşan A
    Rom J Morphol Embryol; 2009; 50(3):341-7. PubMed ID: 19690758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma.
    Kunert-Keil C; Steinmüller F; Jeschke U; Gredes T; Gedrange T
    Acta Histochem; 2011 Dec; 113(8):798-802. PubMed ID: 21168900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
    Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
    Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Novel prognostic marker in invasive breast cancer. ITIH5 expression is abrogated by aberrant promoter methylation].
    Veeck J; Breuer E; Rose M; Chorovicer M; Naami A; Bektas N; Alkaya S; von Serényi S; Horn F; Hartmann A; Knüchel R; Dahl E
    Pathologe; 2008 Nov; 29 Suppl 2():338-46. PubMed ID: 18810445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER-2 status discrepancy between primary breast cancer and metastatic sites. Impact on target therapy.
    Santinelli A; Pisa E; Stramazzotti D; Fabris G
    Int J Cancer; 2008 Mar; 122(5):999-1004. PubMed ID: 17973263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.